These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 8019278)

  • 1. Active cascade testing for carriers of cystic fibrosis gene.
    Super M; Schwarz MJ; Malone G; Roberts T; Haworth A; Dermody G
    BMJ; 1994 Jun; 308(6942):1462-7. PubMed ID: 8019278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antenatal screening for cystic fibrosis: a trial of the couple model.
    Livingstone J; Axton RA; Gilfillan A; Mennie M; Compton M; Liston WA; Calder AA; Gordon AJ; Brock DJ
    BMJ; 1994 Jun; 308(6942):1459-62. PubMed ID: 8019277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening.
    Miedzybrodzka ZH; Hall MH; Mollison J; Templeton A; Russell IT; Dean JC; Kelly KF; Marteau TM; Haites NE
    BMJ; 1995 Feb; 310(6976):353-7. PubMed ID: 7866213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cascade carrier-testing in cystic fibrosis.
    Roberts T; Schwarz MJ; Kerr-Liddell R; Hinks JL; Super M
    Paediatr Respir Rev; 2003 Dec; 4(4):293-8. PubMed ID: 14629951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability of carrier screening for cystic fibrosis during pregnancy in a German population.
    Jung U; Urner U; Grade K; Coutelle C
    Hum Genet; 1994 Jul; 94(1):19-24. PubMed ID: 8034290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highlighting the impact of cascade carrier testing in cystic fibrosis families.
    Duguépéroux I; L'Hostis C; Audrézet MP; Rault G; Frachon I; Bernard R; Parent P; Blayau M; Schmitt S; Génin E; Férec C; Scotet V
    J Cyst Fibros; 2016 Jul; 15(4):452-9. PubMed ID: 27013383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antenatal screening for cystic fibrosis.
    Cuckle H; Quirke P; Sehmi I; Lewis F; Murray J; Cross D; Cuckle P; Ozols B
    Br J Obstet Gynaecol; 1996 Aug; 103(8):795-9. PubMed ID: 8760710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active cascade screening for cystic fibrosis.
    Marteau T
    BMJ; 1994 Jun; 308(6942):1468. PubMed ID: 8019279
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcomes of a cystic fibrosis carrier testing clinic for couples.
    Christie LM; Ingrey AJ; Turner GM; Proos AL; Watts GE
    Med J Aust; 2009 Nov; 191(9):499-501. PubMed ID: 19883345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP.
    Hartley NE; Scotcher D; Harris H; Williamson P; Wallace A; Craufurd D; Harris R
    J Med Genet; 1997 Jun; 34(6):459-64. PubMed ID: 9192264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis carrier testing in early pregnancy by general practitioners.
    Harris H; Scotcher D; Hartley N; Wallace A; Craufurd D; Harris R
    BMJ; 1993 Jun; 306(6892):1580-3. PubMed ID: 8329921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis carrier population screening in the primary care setting.
    Loader S; Caldwell P; Kozyra A; Levenkron JC; Boehm CD; Kazazian HH; Rowley PT
    Am J Hum Genet; 1996 Jul; 59(1):234-47. PubMed ID: 8659530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for carriers of cystic fibrosis--a general practitioner's perspective.
    Modell M
    BMJ; 1993 Oct; 307(6908):849-52. PubMed ID: 8401130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between carrier screening and incidence of cystic fibrosis.
    Castellani C; Picci L; Tamanini A; Girardi P; Rizzotti P; Assael BM
    JAMA; 2009 Dec; 302(23):2573-9. PubMed ID: 20009057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for cystic fibrosis. Should begin with cascade screening.
    Super M; Schwarz MJ; Malone G; Roberts T; Haworth A; Dermody G
    BMJ; 1994 Oct; 309(6958):877-8. PubMed ID: 7950637
    [No Abstract]   [Full Text] [Related]  

  • 16. Population-based carrier screening for cystic fibrosis in Victoria: the first three years experience.
    Massie J; Petrou V; Forbes R; Curnow L; Ioannou L; Dusart D; Bankier A; Delatycki M
    Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):484-9. PubMed ID: 19780730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Suddenly Having two Positive People who are Carriers is a Whole New Thing" - Experiences of Couples Both Identified as Carriers of Cystic Fibrosis Through a Population-Based Carrier Screening Program in Australia.
    Ioannou L; Delatycki MB; Massie J; Hodgson J; Lewis S
    J Genet Couns; 2015 Dec; 24(6):987-1000. PubMed ID: 25925605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis heterozygote screening in 5,161 pregnant women.
    Witt DR; Schaefer C; Hallam P; Wi S; Blumberg B; Fishbach A; Holtzman J; Kornfeld S; Lee R; Nemzer L; Palmer R
    Am J Hum Genet; 1996 Apr; 58(4):823-35. PubMed ID: 8644747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of cystic fibrosis in Denmark. Implications for genetic counselling, carrier diagnosis and prenatal diagnosis.
    Schwartz M; Brandt NJ; Koch C; Lanng S; Schiøtz PO
    Acta Paediatr; 1992; 81(6-7):522-6. PubMed ID: 1392366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.